Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?3.75 RB, SLActive? 6mm, RXD: medical device reports filed with FDA

1,264 reports name it, 2021–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

1,264
device reports naming the brand
0% of all MAUDE reports · about 262 a year
352
reports, 12 months to August 2026
380 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,264 reports that name the brand "BLX ?3.75 RB, SLActive? 6mm, RXD" (endosseous dental implant), received between September 2021 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

352 reports arrived in the 12 months to August 2026, close to the 380 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (72.9%), loss of osseointegration (21.5%) and difficult to insert (0.5%). The patient problems coded most often are fibrosis, pain and hemorrhage/blood loss/bleeding. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04385Sep 2021: 9Oct 2021: 7Nov 2021: 8Dec 2021: 32022Jan 2022: 10Feb 2022: 6Mar 2022: 20Apr 2022: 16May 2022: 11Jun 2022: 12Jul 2022: 13Aug 2022: 16Sep 2022: 4Oct 2022: 11Nov 2022: 13Dec 2022: 202023Jan 2023: 16Feb 2023: 18Mar 2023: 16Apr 2023: 21May 2023: 8Jun 2023: 15Jul 2023: 16Aug 2023: 15Sep 2023: 15Oct 2023: 20Nov 2023: 21Dec 2023: 142024Jan 2024: 9Feb 2024: 10Mar 2024: 15Apr 2024: 21May 2024: 20Jun 2024: 24Jul 2024: 25Aug 2024: 34Sep 2024: 12Oct 2024: 62Nov 2024: 37Dec 2024: 332025Jan 2025: 21Feb 2025: 28Mar 2025: 31Apr 2025: 10May 2025: 0Jun 2025: 85Jul 2025: 28Aug 2025: 33Sep 2025: 17Oct 2025: 44Nov 2025: 27Dec 2025: 252026Jan 2026: 22Feb 2026: 39Mar 2026: 27Apr 2026: 23May 2026: 34Jun 2026: 38Jul 2026: 26Aug 2026: 30

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

01753492021: 2720212022: 15220222023: 19520232024: 30220242025: 34920252026: 2392026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,264
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report92.5%1,169
Voluntary report0%0
User facility report0%0
Distributor report7.5%95
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate92272.9%62.8%
Loss of osseointegration27221.5%22.4%
Difficult to insertthe device was hard to insert60.5%0.4%
Fracturea broken bone30.2%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis43734.6%
Painpain, site not specified26621%
Hemorrhage/blood loss/bleeding745.9%
Inflammationinflammation715.6%
Swelling/ edema614.8%
Hyperresponsive to stimuli302.4%
Fistula262.1%
Hypersensitivity/allergic reaction252%
Abscessa collection of pus110.9%
Sinus perforation110.9%
Failure of implant30.2%
Numbnessnumbness10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?3.75 RB, SLActive? 6mm, RXDProduct code DZEAll MAUDE reports
Reports1,2643,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer92.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?3.75 RB, SLActive? 6mm, RXD reports

How many FDA reports name BLX ?3.75 RB, SLActive? 6mm, RXD?

1,264 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 352 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (72.9%), loss of osseointegration (21.5%), difficult to insert (0.5%) and fracture (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (92.5%) and distributor reports (7.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?3.75 RB, SLActive? 6mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.